<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: FTC Seeks to Halt &#8216;Pay to Delay&#8217; Drug Payments</title>
	<atom:link href="http://www.businesspundit.com/ftc-seeks-to-halt-pay-to-delay-drug-payments/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.businesspundit.com/ftc-seeks-to-halt-pay-to-delay-drug-payments/</link>
	<description>Entrepreneurship, Startup Companies and Business Philosophy</description>
	<lastBuildDate>Sat, 20 Mar 2010 01:45:14 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: John</title>
		<link>http://www.businesspundit.com/ftc-seeks-to-halt-pay-to-delay-drug-payments/comment-page-1/#comment-15559</link>
		<dc:creator>John</dc:creator>
		<pubDate>Mon, 13 Jul 2009 17:31:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.businesspundit.com/?p=12736#comment-15559</guid>
		<description>Though the practice is abhorrent as described, I do admire the ingenuity it represents.  The patent-driven drug industry needs the premium so they can cevote more time to discovery, trials and approval process.  How many drugs go through every detail only to fail to get approval in the end?

I, too, dislike paying for the patent (I recently forked out over $100 for 1/2 oz of ear drops), but would rather overcome with competition.  For example, establish a non-profit to counter the brand-names&#039; &quot;pay-to-delay&quot; proposals.

Most of the time, it should be possible to &quot;buy&quot; the generic back with a little song and dance about how many people they&#039;ll be helping (it&#039;s probably part of the mission statement, but the generic manufacturer could stand a reminder).  But it should also have the power to offer financial incentives (it doesn&#039;t have to be as much as the brand-name&#039;s offer. after all, they&#039;ll get money from selling the generic, too).</description>
		<content:encoded><![CDATA[<p>Though the practice is abhorrent as described, I do admire the ingenuity it represents.  The patent-driven drug industry needs the premium so they can cevote more time to discovery, trials and approval process.  How many drugs go through every detail only to fail to get approval in the end?</p>
<p>I, too, dislike paying for the patent (I recently forked out over $100 for 1/2 oz of ear drops), but would rather overcome with competition.  For example, establish a non-profit to counter the brand-names&#8217; &#8220;pay-to-delay&#8221; proposals.</p>
<p>Most of the time, it should be possible to &#8220;buy&#8221; the generic back with a little song and dance about how many people they&#8217;ll be helping (it&#8217;s probably part of the mission statement, but the generic manufacturer could stand a reminder).  But it should also have the power to offer financial incentives (it doesn&#8217;t have to be as much as the brand-name&#8217;s offer. after all, they&#8217;ll get money from selling the generic, too).</p>
]]></content:encoded>
	</item>
</channel>
</rss>
